Status and phase
Conditions
Treatments
About
To compare the effect of rosuvastatin to protease inhibitor switching on fasting total cholesterol over 12 weeks.
Full description
To compare the effects of rosuvastatin to protease inhibitor switching on:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Any statin in the previous 12 weeks
Previous statin-induced myopathy or hepatitis
History of coronary artery disease, stroke or any other indication for the use of statin therapy (hyperlipidaemia: genetic, secondary or idiopathic)
Concurrent use of:
Contraindication to rosuvastatin therapy:
No potent switch ART drug available to replace the current ritonavir-boosted protease inhibitor
Known intolerance to rosuvastatin or the proposed switch ART drug
Women attempting or likely to become pregnant, or who are pregnant or breast-feeding
A patient with a history or current evidence of any condition, therapy, or laboratory abnormality, or other circumstance that might confound the results of the study, or interfere with the patient's participation for the full duration of the study
Unable to complete study procedures
Primary purpose
Allocation
Interventional model
Masking
21 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal